• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲毛霉菌病的流行病学趋势,与其他大洲的比较。

Epidemiological Trends of Mucormycosis in Europe, Comparison with Other Continents.

机构信息

First Department of Medicine, Laiko Hospital, National and Kapodistrian University of Athens, 11527, Athens, Greece.

Intensive Care Unit, Laiko Hospital, 11527, Athens, Greece.

出版信息

Mycopathologia. 2024 Nov 20;189(6):100. doi: 10.1007/s11046-024-00907-5.

DOI:10.1007/s11046-024-00907-5
PMID:39565510
Abstract

Mucormycosis is an invasive fungal infection, caused by fungi of the order Mucorales, and it is associated with high morbidity and mortality. The epidemiology of mucormycosis is evolving. The incidence, underlying risk factors, clinical presentation, as well as the responsible mucoralean agents, vary by geographic region. The estimated incidence in developed countries ranges from less than 0.06 to 0.3 cases per 100,000 population per year, while in India, it reaches approximately 14 cases per 100,000 population per year, which is about 80 times higher. In European countries the estimated incidence ranges from less than 0.04 to 0.12 per 100,000 population per year. Diabetes mellitus (DM) is the leading underlying disease globally. In Europe, hematological malignancies are the most common risk factor for mucormycosis, while in Asia diabetes predominates. The rhino-cerebral form of mucormycosis is most commonly seen in patients with DM, whereas pulmonary mucormycosis in patients with hematological malignancies and transplants. The most common species globally is Rhizopus arrhizus, whereas new emerging species only occasionally cause infection in Europe. However, vigilance is required, as they may raise concerns-especially in light of climate change- due to their potential to cause serious infections in both immunocompetent and immunosuppressed individuals.

摘要

毛霉病是一种侵袭性真菌感染,由毛霉目真菌引起,其发病率和死亡率均较高。毛霉病的流行病学正在发生变化。毛霉病的发病率、潜在危险因素、临床表现以及致病毛霉种类因地域不同而有所差异。在发达国家,发病率估计为每年每 10 万人中少于 0.06 至 0.3 例,而在印度,每年每 10 万人中约有 14 例,发病率大约高 80 倍。在欧洲国家,发病率估计为每年每 10 万人中少于 0.04 至 0.12 例。糖尿病(DM)是全球最主要的潜在疾病。在欧洲,血液系统恶性肿瘤是毛霉病最常见的危险因素,而在亚洲则以糖尿病为主。鼻-脑型毛霉病最常见于糖尿病患者,而肺型毛霉病则常见于血液系统恶性肿瘤和移植患者。全球最常见的物种是根毛霉,而新出现的物种在欧洲偶尔引起感染。然而,需要保持警惕,因为它们可能会引起关注,尤其是考虑到气候变化,因为它们有可能导致免疫功能正常和免疫抑制个体发生严重感染。

相似文献

1
Epidemiological Trends of Mucormycosis in Europe, Comparison with Other Continents.欧洲毛霉菌病的流行病学趋势,与其他大洲的比较。
Mycopathologia. 2024 Nov 20;189(6):100. doi: 10.1007/s11046-024-00907-5.
2
Global Epidemiology of Mucormycosis.毛霉病的全球流行病学
J Fungi (Basel). 2019 Mar 21;5(1):26. doi: 10.3390/jof5010026.
3
A prospective study of mucormycosis in north India: experience from a tertiary care hospital.印度北部毛霉菌病的前瞻性研究:来自一家三级医疗医院的经验。
Med Mycol. 2015 Apr;53(3):248-57. doi: 10.1093/mmy/myu086. Epub 2015 Jan 13.
4
The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports.毛霉病的流行病学和临床表现:病例报告的系统评价和荟萃分析。
Clin Microbiol Infect. 2019 Jan;25(1):26-34. doi: 10.1016/j.cmi.2018.07.011. Epub 2018 Jul 21.
5
Mucormycosis in Iran: A six-year retrospective experience.伊朗的毛霉病:六年回顾性经验。
J Mycol Med. 2018 Jun;28(2):269-273. doi: 10.1016/j.mycmed.2018.02.014. Epub 2018 Mar 12.
6
Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.儿童侵袭性毛霉病:基于两个登记处对欧洲和非欧洲国家的一项流行病学研究。
BMC Infect Dis. 2016 Nov 10;16(1):667. doi: 10.1186/s12879-016-2005-1.
7
Mucormycosis in India: unique features.印度的毛霉病:独特特征
Mycoses. 2014 Dec;57 Suppl 3:85-90. doi: 10.1111/myc.12243. Epub 2014 Sep 3.
8
First Case of Rhinocerebral Mucormycosis Caused by Lichtheimia ornata, with a Review of Lichtheimia Infections.首例由光单孢菌引起的鼻脑毛霉病,伴光单孢菌感染综述。
Mycopathologia. 2020 Jun;185(3):555-567. doi: 10.1007/s11046-020-00451-y. Epub 2020 May 9.
9
Epidemiology of Mucormycosis in India.印度毛霉菌病的流行病学
Microorganisms. 2021 Mar 4;9(3):523. doi: 10.3390/microorganisms9030523.
10
Epidemiology and clinical manifestations of mucormycosis.毛霉病的流行病学和临床表现。
Clin Infect Dis. 2012 Feb;54 Suppl 1:S23-34. doi: 10.1093/cid/cir866.

引用本文的文献

1
De novo genome sequencing and comparative analyses of the clinically relevant species Mucor ardhlaengiktus, Mucor circinelloides, Mucor griseocyanus, and Mucor janssenii.临床上相关物种阿尔德朗吉图斯毛霉、卷枝毛霉、灰蓝毛霉和扬森毛霉的从头基因组测序及比较分析。
Med Mycol. 2025 Sep 2;63(9). doi: 10.1093/mmy/myaf081.
2
Molecular epidemiology, diversity, and antifungal susceptibility profiles of clinical and environmental mucorales: a five-year multicenter study in Iran (2018-2023).临床和环境毛霉目真菌的分子流行病学、多样性及抗真菌药敏谱:伊朗一项为期五年的多中心研究(2018 - 2023年)
BMC Infect Dis. 2025 Jul 1;25(1):849. doi: 10.1186/s12879-025-11189-7.
3

本文引用的文献

1
Epidemiology, Clinical Manifestations, and Outcome of Mucormycosis in Solid Organ Transplant Recipients: A Systematic Review of Reported Cases.实体器官移植受者毛霉菌病的流行病学、临床表现及转归:病例报告的系统评价
Open Forum Infect Dis. 2024 Jan 30;11(6):ofae043. doi: 10.1093/ofid/ofae043. eCollection 2024 Jun.
2
Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India.COVID-19 相关肺毛霉病的危险因素、死亡率和生存预测因素:来自印度的一项多中心回顾性研究。
Clin Microbiol Infect. 2024 Mar;30(3):368-374. doi: 10.1016/j.cmi.2023.12.006. Epub 2023 Dec 9.
3
Impact of COVID-19 on the prevalence of oral and maxillofacial disorders: A retrospective cohort study.
2019冠状病毒病对口腔颌面部疾病患病率的影响:一项回顾性队列研究。
Sci Prog. 2025 Jan-Mar;108(1):368504251326453. doi: 10.1177/00368504251326453. Epub 2025 Mar 16.
Improving Diagnosis of Pulmonary Mucormycosis: Leads From a Contemporary National Study of 114 Cases.
提高肺毛霉菌病诊断水平:来自 114 例当代全国性研究的线索。
Chest. 2023 Nov;164(5):1097-1107. doi: 10.1016/j.chest.2023.06.039. Epub 2023 Jul 5.
4
Saksenaea vasiformis infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases.赛斯凯纳酵母感染:广泛的腹壁坏死性筋膜炎,并进行了系统评价和 65 例病例分析。
Mycoses. 2023 Aug;66(8):697-704. doi: 10.1111/myc.13592. Epub 2023 Apr 24.
5
COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases.COVID-19 相关毛霉病:958 例的系统回顾和荟萃分析。
Clin Microbiol Infect. 2023 Jun;29(6):722-731. doi: 10.1016/j.cmi.2023.03.008. Epub 2023 Mar 13.
6
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes.非洲的毛霉菌病:流行病学、诊断和治疗结果。
Mycoses. 2023 Jul;66(7):555-562. doi: 10.1111/myc.13581. Epub 2023 Mar 7.
7
Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases.阿波菲霉属引起的毛霉病:来自印度西部一家三级护理医院的经验及全球病例的系统评价
Mycoses. 2023 Mar;66(3):181-195. doi: 10.1111/myc.13538. Epub 2022 Oct 20.
8
Disease burden and demographic characteristics of mucormycosis: A nationwide population-based study in Taiwan, 2006-2017.2006-2017 年台湾全国性基于人群的研究:毛霉菌病的疾病负担和人口统计学特征。
Mycoses. 2022 Nov;65(11):1001-1009. doi: 10.1111/myc.13484. Epub 2022 Jun 30.
9
Necrotizing Skin and Soft Tissue Infection Due to Species and Species Complex Following Open Tibia Fracture.开放性胫骨骨折后由[具体菌种]和[菌种复合体]引起的坏死性皮肤和软组织感染
Diagnostics (Basel). 2022 May 7;12(5):1163. doi: 10.3390/diagnostics12051163.
10
Cutaneous Invasive Fungal Infections with Species in Immunocompetent Patients in Europe: A Systematic Review and Case Report.欧洲免疫功能正常患者皮肤侵袭性真菌感染的系统评价与病例报告
Plast Reconstr Surg Glob Open. 2022 Apr 8;10(4):e4230. doi: 10.1097/GOX.0000000000004230. eCollection 2022 Apr.